ALFA FinderBSE filing, NSE: DRREDDY. Summary written from the filing by ALFA Finder's alert engine.
Dr. Reddy's Laboratories Ltd: key numbers
- Share price
- ₹1,373.00
- Market cap
- ₹1,14,601 Cr
- Revenue (annual)
- ₹33,700 Cr
- Net profit (annual)
- ₹4,196 Cr
- P/E (TTM)
- 40.9×Sector 43.0×
- Promoter holding
- 26.63%-0.01% QoQ
- FII holding
- 20.30%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Reddy's Laboratories Ltd
All →Dr. Reddy's Laboratories Regulatory Approval
Dr. Reddy's Laboratories received marketing authorization from Brazil's ANVISA for its generic semaglutide injection. The approval targets Brazil's diabetes market, estimated at approximately USD 244.6 million.
Dr. Reddy's Laboratories Other Announcement
Dr Reddy's KMP Erez Israeli sold 460,276 ADRs to cover the exercise of 591,270 ADRs allotted under ESOP. The disposal is valued at about ₹61.76 Crore.
- Value
- ₹61.76 Cr
Dr. Reddy's Laboratories Employee Stock Options
Dr. Reddy's allotted 5,91,270 equity shares to employees on exercise of stock options under its ADR ESOP Scheme 2007. Exercise prices ranged from Re.1 to Rs.1,060.20 per share.
Dr. Reddy's Laboratories Price Movement Clarification
Dr. Reddy's confirms FDA tentative approval for its lenacapavir HIV shot. The company states the news is not material and has no material impact.
Dr. Reddy's Laboratories Business Update
Dr Reddy's says USFDA closed its PAI and GMP inspection at Srikakulam FTO-SEZ Process Unit-02 with VAI classification. The outcome is closed with no monetary penalty.
Dr. Reddy's Laboratories Earnings Call Transcript: Key Takeaways
Revenue declined 1.5% YoY as lower Revlimid sales in North America offset strong double-digit growth in base business and emerging markets.
- Call
- Guides 25% growth
Other capital structure change announcements
All →Tata Steel Capital Structure Change
Tata Steel's stake in subsidiary CPDPL rose from 51% to 57.5% via conversion of preference shares. CPDPL remains a subsidiary; no fresh capital was subscribed.
Filatex India Capital Structure Change
Filatex India invested Rs.13.00 Crore by subscribing 1.30 crore rights shares of wholly owned subsidiary Ecosis at Rs.10. Funds support the polyester recycling project, loan repayment and working capital.
- Value
- ₹13.00 Cr
Zydus Lifesciences Capital Structure Change
LIC sold 20,242,068 Zydus Lifesciences shares via market sale, cutting its stake from 5.21 percent to 3.18 percent. Non-promoter SAST disclosure covering 28.08.2025 to 05.11.2026.
Indian Oil Corporation Capital Structure Change
LIC, a non-promoter shareholder, reported a market sale of 28,34,86,368 shares in Indian Oil, cutting its holding from 7.887% to 5.879%. No monetary value is stated.
- Promoter stake change
- -2.01%
Kirloskar Oil Engines Capital Structure Change
Kirloskar Oil Engines signed a shareholders' agreement with TPG for its subsidiary Arka Fincap. TPG's investment totals ₹800 Crore across two tranches, the second conditional.
- Value
- ₹800.0 Cr
Ace Software Exports Ltd Partly Paidup Capital Structure Change
Ace Software Exports approved a ₹30.25 second and final call on 54,71,101 partly paid shares. The record date is 20 November 2026.
- Value
- ₹16.55 Cr